MIST
NASDAQ
$1.18
Milestone Pharmaceuticals Inc (MIST)
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular drugs. The company is headquartered in Montral, Canada.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $6.33 (+436.44%)
Market Cap
$150M
Free Cash Flow Yield
-34.41%
Beta (5Y)
1.53
Price Chart
Valuation
Market Cap$150M
P/S88.63
P/B4.51
Profitability
Total Revenue (TTM)$238K
Gross Profit (TTM)$1.77M
EBITDA-$65M
Operating Margin-9942%
EPS-$0.77
Financial Health
Debt-to-Equity161.4%
Free Cash Flow Yield-34.41%
Growth & Risk
EPS 5Y CAGR-14.90%
FCF 5Y CAGR+2.67%
Beta (5Y)1.53
Sharpe Ratio-0.18